Atrys Health (BME:ATRY), founded in 2015, is a Spanish multinational that provides predictive, preventive, diagnostic, and precision medical treatment services. It is a pioneer in the fields of telemedicine and next-generation radiotherapy. The company has a team of more than 2,500 professionals and is present in Spain, Portugal, Switzerland, and Latin America. Atrys organises its activity around five business units: telemedicine, oncology, diagnostics, prevention, and big data. The company has been listed on the BME Growth Market (BME) since 2016 and is part of the IBEX MAB® 15 index.
Figures in thousands. Pro forma data including full year impact of acquisitions carried out.
(*) Information for the 2022 financial year updated on 25 January 2022.
Would you like to get in touch with the Investor Relations department?
Tell us how we can help you